Patient 2 was a 22-year-old unmarried young man. At intake, he was a university student and a professional football athlete. He reported having alopecia for several years and resolved Guillain-Barre syndrome in the past months. He had a history of major depressive episodes, initiating in his childhood. Presenting complaints included persistent depressive symptoms, comorbid with anxiety disorders [specific phobia (heights) and agoraphobia], with a significant impact on his academic and athletic performance. The patient had no history of drug or alcohol abuse and no previous psychiatric admissions but reports a suspected family history of MDD (father). This was the second time the patient sought professional help for the presenting symptoms which were addressed with psychotherapy and pharmacotherapy (sertraline 50 mg). This time the patient's treatment of choice was FLOW. Patient 2 initiated Flow at the same time as psychotherapy and completed Protocol 1 (17 tDCS sessions).